How many insider declarations has Rieger Jayson filed?

Rieger Jayson has filed 4 public insider declarations with SEC (Form 4).

What is Rieger Jayson's role?

Rieger Jayson's reported role is not specified by the regulator across the filings.

Which companies does Rieger Jayson report trades for?

Rieger Jayson reports trades for Verrica Pharmaceuticals Inc..

What is Rieger Jayson's declared buy vs sell volume?

Across the available history, declared buys total 456k€ and disposals 0.

← Executives ★ Sign in to follow

RJ

Rieger Jayson

CEO

·SEC (Form 4)

Verrica Pharmaceuticals Inc.

Cumul. flow

0

Total declarations

0

Company

€456,203

▲ Purchases (4 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

4

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the full record of transactions filed by Rieger Jayson. Officer active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €456k. History available since 25 November 2025. The latest transaction was filed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Rieger Jayson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Verrica Pharmaceuticals Inc. (US)

Declarations4 total

▲

Rieger Jayson

CEO and PresidentExecutives14 Aug 2026Verrica Pharmaceuticals Inc.

$101,2000SEC ↗

20,000 shares@ US$5.06Common StockSEC:0002043558-26-000005:0

Canonical exit: 12 Nov 2026 (T+90)

▲

Rieger Jayson

CEO and PresidentExecutives17 Aug 2026Verrica Pharmaceuticals Inc.

$24,5500SEC ↗

5,000 shares@ US$4.91Common StockSEC:0002043558-26-000005:1

Canonical exit: 15 Nov 2026 (T+90)

▲

Rieger Jayson

CEO and PresidentExecutives25 Nov 2025Verrica Pharmaceuticals Inc.

$400,11452SEC ↗

94,311 shares@ US$4.2425100.0% of flowCommon StockSEC:0002043558-25-000003:0

Canonical exit: 23 Feb 2026 (T+90)

▲

Rieger Jayson

CEO and PresidentExecutives22 Nov 2024Verrica Pharmaceuticals Inc.

0SEC ↗

280,898 sharesCommon StockSEC:0001415889-24-027711:0

Canonical exit: 20 Feb 2025 (T+90)

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

RJ

Rieger Jayson

CEO

·SEC (Form 4)

Verrica Pharmaceuticals Inc.

Cumul. flow

0

Total declarations

0

Company

€456,203

▲ Purchases (4 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

4

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the full record of transactions filed by Rieger Jayson. Officer active across 1 company, notably Verrica Pharmaceuticals Inc.. In total, 4 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €456k. History available since 25 November 2025. The latest transaction was filed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.